about
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Usin...
Read More17,255 XNAS Volume
XNAS 07 May, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Synlogic Inc is on 14 May 2025 for the purpose of Synlogic Inc First Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Synlogic Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..